Use of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient population

Vista sencilla de ítem
dc.contributor.authorTamma , Pranita
dc.contributor.authorVillegas, María Virginia
dc.contributor.orcidVillegas, María Virginia [0000-0003-1898-9067]
dc.date.accessioned2020-07-15T20:51:25Z
dc.date.available2020-07-15T20:51:25Z
dc.date.issued2017
dc.description.abstractenglishβ-Lactam/β-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum-β-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and the definitive therapy cohort (251 patients). The 30-day case fatality rates and other secondary outcomes were similar in the two therapy groups of the two cohorts and also in the propensity-matched cohorts. BLBLIs might be carbapenem-sparing alternatives for the treatment of BSI due to ESBLs in these patients.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1128/AAC.01094-17
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1098-6596
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlhttps://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/3503
dc.language.isoeng
dc.publisherAmerican Society for Microbiologyspa
dc.publisher.journalAntimicrobial agents and chemotherapyspa
dc.relation.ispartofseriesAntimicrobial agents and chemotherapy, 1098-6596, Vol. 61, Nro. 8, 2017spa
dc.relation.urihttps://aac.asm.org/content/61/8/e01094-17
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2017-06-05
dc.rights.localAcceso abiertospa
dc.subject.decsBeta-Lactamasspa
dc.subject.decsInhibidores de beta-Lactamasasspa
dc.subject.decsCarbapenémicosspa
dc.subject.keywordsESBLsspa
dc.subject.keywordsBloodstream infectionspa
dc.subject.keywordsNeutropeniaspa
dc.titleUse of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient populationspa
dc.title.translatedUse of β-lactam/β-lactamase inhibitors for extended-spectrum-β-lactamase infections: defining the right patient populationspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Pranita D. Tamma, Maria Virginia Villegas_2020.pdf
Tamaño:
142.46 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos